SynthesisObesity surgery2026
Effects of Metabolic and Bariatric Surgery on Serum Uric Acid and its Association with Renal Function, and Visceral Adiposity: A Systematic Review and Meta-Analysis.
Synthesis in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is associated with hyperuricemia through visceral adiposity, inflammation, and impaired renal urate handling. We systematically reviewed PubMed, Embase, Scopus, and Web of Science (January 2025) and meta-analyzed longitudinal changes in serum uric acid (SUA) after metabolic and bariatric surgery (MBS) and associations with creatinine (Cr), blood urea nitrogen (BUN), and waist circumference (WC). Forty-two studies (n = 9,468) were included and assessed using the Newcastle–Ottawa Scale. SUA showed a transient, non-significant rise at 7 days, then declined progressively, with the greatest reduction at 12 months (MD − 1.43 mg/dL; 95% CI − 1.80 to − 1.07). Reductions were larger after Roux-en-Y gastric bypass than sleeve gastrectomy. Meta-regression showed positive associations of postoperative SUA with Cr, WC, and BMI, but not BUN. MBS is associated with sustained urate reduction linked to renal and visceral adiposity improvements.
Indexed as
Identifiers
41840314What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.